173 related articles for article (PubMed ID: 36628830)
1. Age-based risk of end-stage kidney disease in patients with myelomeningocele.
Adams CM; Misseri R; Roth JD; Whittam BM; Guckien ZE; King SJ; Kaefer M; Rink RC; Szymanski KM
J Pediatr Urol; 2023 Apr; 19(2):195.e1-195.e7. PubMed ID: 36628830
[TBL] [Abstract][Full Text] [Related]
2. Urodynamic and imaging findings in infants with myelomeningocele may predict need for future augmentation cystoplasty.
Corona LE; Lee T; Marchetti K; S Streur C; Ivancic V; Kraft KH; Bloom DA; Wan J; Park JM
J Pediatr Urol; 2019 Dec; 15(6):644.e1-644.e5. PubMed ID: 31653462
[TBL] [Abstract][Full Text] [Related]
3. Need for botulinum toxin injection and bladder augmentation after isolated bladder outlet procedure in pediatric patients with myelomeningocele.
Smith MC; Strine AC; DeFoor WR; Minevich E; Noh P; Sheldon CA; Reddy PP; VanderBrink BA
J Pediatr Urol; 2020 Feb; 16(1):32.e1-32.e8. PubMed ID: 31839471
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and predictors of chronic kidney disease in children with myelomeningocele: a nationwide cohort study.
Doğan ÇS; Taner S; Tiryaki BD; Alaygut D; Özkayın N; Kara A; Gençler A; Pınarbaşı AS; Nalçacıoğlu H; Yüksel S; Akacı O; Yılmaz EK; Yavuz S; Doğan K; Gülşan RYÇ; Aksoy GK; Çiçek N; Aksu B; Küçük N; Altugan FŞ; Selçuk ŞZ; Baştuğ F; Erfidan G; Atmış B; Gökçeoğlu AU; Önder ENA; Elmacı AM; Cengiz N; Gülleroğlu K; Yılmaz EB; Tayfur AÇ; Yılmaz GG; Yel S; Pehlivanoğlu C; Akgün C; Kara MA; Kılıç BD; Şimşek ÖÖ; Yucal M; Ağar BE; Gürgöze MK; Yağmur İ; Madsar Ö; Karalı DT; Girişgen İ; Bodur ED; Çomak E; Gökçe İ; Kaya M; Tabel Y; Günay N; Gülmez R; Çalışkan S
Pediatr Nephrol; 2024 May; 39(5):1509-1519. PubMed ID: 38040872
[TBL] [Abstract][Full Text] [Related]
5. Initial urological evaluation and management of children with neurogenic bladder due to myelomeningocele.
Sager C; Burek C; Corbetta JP; Weller S; Ruiz J; Perea R; Lago E; Gomez Y; Durán V; López JC
J Pediatr Urol; 2017 Jun; 13(3):271.e1-271.e5. PubMed ID: 28215830
[TBL] [Abstract][Full Text] [Related]
6. Urological outcome after myelomeningocele: 20 years of follow-up.
Thorup J; Biering-Sorensen F; Cortes D
BJU Int; 2011 Mar; 107(6):994-9. PubMed ID: 20860652
[TBL] [Abstract][Full Text] [Related]
7. Update on Urological Management of Spina Bifida from Prenatal Diagnosis to Adulthood.
Snow-Lisy DC; Yerkes EB; Cheng EY
J Urol; 2015 Aug; 194(2):288-96. PubMed ID: 25839383
[TBL] [Abstract][Full Text] [Related]
8. [Kidney transplantation into a neurogenic bladder in myelomeningocele patient (MMC)].
Drozynska-Duklas M; Załuska-Leśniewska I; Bałasz-Chmielewska I; Czarniak P; Zurowska A
Pol Merkur Lekarski; 2008; 24 Suppl 4():117-8. PubMed ID: 18924522
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of videourodynamic study in the decision-making of surgical intervention and bladder management for neurogenic lower urinary tract dysfunction among patients with myelomeningocele.
Yu WR; Kuo HC
Int Urol Nephrol; 2022 Aug; 54(8):1815-1824. PubMed ID: 35608803
[TBL] [Abstract][Full Text] [Related]
10. Intradetrusor Injections of Botulinum Toxin Type A in Children With Spina Bifida: A Multicenter Study.
Hascoet J; Peyronnet B; Forin V; Baron M; Capon G; Prudhomme T; Allenet C; Tournier S; Maurin C; Cornu JN; Bouali O; Peycelon M; Arnaud A; Renaux-Petel M; Liard A; Karsenty G; Manunta A; Game X
Urology; 2018 Jun; 116():161-167. PubMed ID: 29522865
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of cutaneous vesicostomy in patients with neuropathic bladder caused by spina bifida.
Dönmez Mİ; Carrasco A; Saltzman AF; Vemulakonda V; Wilcox DT
J Pediatr Urol; 2017 Dec; 13(6):622.e1-622.e4. PubMed ID: 28669586
[TBL] [Abstract][Full Text] [Related]
12. Comparison of risk of anticholinergic utilization for treatment of neurogenic bladder between in utero or postnatal myelomeningocele repair.
Zaccaria L; Daugherty M; Grant C; Strine AC; Reddy PP; DeFoor WR; Minevich E; Lim FY; VanderBrink BA
J Pediatr Urol; 2021 Aug; 17(4):525.e1-525.e7. PubMed ID: 34074608
[TBL] [Abstract][Full Text] [Related]
13. Additional Surgeries after Bladder Augmentation in Patients with Spina Bifida in the 21st Century.
Szymanski KM; Misseri R; Whittam B; Hollowell N; Hardacker RE; Swenson CR; Kaefer M; Rink RC; Cain MP
J Urol; 2020 Jun; 203(6):1207-1213. PubMed ID: 31951496
[TBL] [Abstract][Full Text] [Related]
14. Spinal cord transection before scoliosis correction in myelomeningocele may improve bladder function.
Linthorst JI; Veenboer PW; Dik P; Pruijs HE; Han SK; de Kort LM; de Jong TP
Neurourol Urodyn; 2014 Jan; 33(1):121-8. PubMed ID: 23423779
[TBL] [Abstract][Full Text] [Related]
15. Improved bladder function after prophylactic treatment of the high risk neurogenic bladder in newborns with myelomentingocele.
Kaefer M; Pabby A; Kelly M; Darbey M; Bauer SB
J Urol; 1999 Sep; 162(3 Pt 2):1068-71. PubMed ID: 10458433
[TBL] [Abstract][Full Text] [Related]
16. Does surgical release of secondary spinal cord tethering improve the prognosis of neurogenic bladder in children with myelomeningocele?
Tarcan T; Onol FF; Ilker Y; Simsek F; Ozek M
J Urol; 2006 Oct; 176(4 Pt 1):1601-6; discussion 1606. PubMed ID: 16952698
[TBL] [Abstract][Full Text] [Related]
17. Factors predicting the success of intradetrusor onabotulinum toxin-A treatment in children with neurogenic bladders due to myelomeningocele: The outcomes of a large cohort.
Danacioglu YO; Keser F; Ersoz C; Polat S; Avci AE; Kalkan S; Silay MS
J Pediatr Urol; 2021 Aug; 17(4):520.e1-520.e7. PubMed ID: 33712371
[TBL] [Abstract][Full Text] [Related]
18. Intractable high-pressure bladder in female infants with spina bifida: clinical characteristics and use of vesicostomy.
Lee MW; Greenfield SP
Urology; 2005 Mar; 65(3):568-71. PubMed ID: 15780378
[TBL] [Abstract][Full Text] [Related]
19. First 60 fetal in-utero myelomeningocele repairs at Saint Louis Fetal Care Institute in the post-MOMS trial era: hydrocephalus treatment outcomes (endoscopic third ventriculostomy versus ventriculo-peritoneal shunt).
Elbabaa SK; Gildehaus AM; Pierson MJ; Albers JA; Vlastos EJ
Childs Nerv Syst; 2017 Jul; 33(7):1157-1168. PubMed ID: 28470384
[TBL] [Abstract][Full Text] [Related]
20. Urodynamic Findings and Renal Function in Children with Neurogenic Bladder after Myelomeningocele.
Korzeniecka-Kozerska A; Porowski T; Bagińska J; Wasilewska A
Urol Int; 2015; 95(2):146-52. PubMed ID: 26067248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
